Global Next Generation Cancer Diagnostics Market Size, Status and Forecast 2020-2026
Market Analysis and Insights: Global Next Generation Cancer Diagnostics Market
The global Next Generation Cancer Diagnostics market size is projected to reach US$ 6389.9 million by 2026, from US$ 5351.3 million in 2020, at a CAGR of 18.5%% during 2021-2026.
Global Next Generation Cancer Diagnostics Scope and Market Size
Next Generation Cancer Diagnostics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Next Generation Cancer Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Cepheid
Koninklijke Philips N.V
F. Hoffmann-La Roche Ltd
Qiagen
Novartis AG
Abbott
Thermo Fisher Scientific
Opko Health
Myriad Genetics
Agilent Technologies
GE Healthcare
PerkinElmer
Genomic Health
Illumina
Hologic
Almac Group
Janssen Global Services
Sysmex Corporation
Next Generation Sequencing
qPCR & Multiplexing
DNA Microarrays
Other
Hospitals
Clinics
Other
North America
Europe
China
Japan
Southeast Asia
India
The global Next Generation Cancer Diagnostics market size is projected to reach US$ 6389.9 million by 2026, from US$ 5351.3 million in 2020, at a CAGR of 18.5%% during 2021-2026.
Global Next Generation Cancer Diagnostics Scope and Market Size
Next Generation Cancer Diagnostics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Next Generation Cancer Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Cepheid
Koninklijke Philips N.V
F. Hoffmann-La Roche Ltd
Qiagen
Novartis AG
Abbott
Thermo Fisher Scientific
Opko Health
Myriad Genetics
Agilent Technologies
GE Healthcare
PerkinElmer
Genomic Health
Illumina
Hologic
Almac Group
Janssen Global Services
Sysmex Corporation
Market segment by Type, the product can be split into
Next Generation Sequencing
qPCR & Multiplexing
DNA Microarrays
Other
Market segment by Application, split into
Hospitals
Clinics
Other
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.